Chair of Health Economics and Rational Use of Drugs, Department of Pharmacology. University of Málaga, Boulevard Louis Pasteur, 32, 29071, Málaga, Spain.
Pharmacoeconomics: Clinical and Economic Evaluation of Pharmaceutical Drugs and Palliative Care, Institute of Biomedical Research in Malaga (IBIMA), Málaga, Spain.
Int J Clin Pharm. 2021 Jun;43(3):524-531. doi: 10.1007/s11096-020-01158-2. Epub 2020 Sep 29.
Background Community pharmacy services play an important role in controlling some factors related to medicine use and patients can benefit from these services to improve the adherence and knowledge of their medications, besides to reduce medicine-related problems. Objective The aim of the REVISA project is to carry out a study on preliminary implementation of the medicines use review service in Spanish community pharmacies. Setting Sixty-four community pharmacies from all regions of Spain. Method A preliminary implementation, cross-sectional multicentre study was conducted using a convenience sample of voluntary community pharmacies. A structured interview enabled to pharmacists to obtain a better understanding of patient's medicines use. Main outcome measure Medicines use review-related time and cost, satisfaction and willingness to pay. Results A total of 495 patients were enrolled. The mean age of the patients was 66.1 years, with the majority females (56.4%) and a mean consumption of 5.7 medicines. A total of 2811 medicines were evaluated and 550 referral recommendations were made (29.8% to Primary Care). The mean time employed by the pharmacists in the medicines use review service was 52.8 min (medicines use review-related cost of €17.27). Most patients expressed a high level of satisfaction with this service (98.5%) and a willingness to pay for it (84%). Conclusion Medicines use review service in community pharmacies in Spain can be delivered, that it appears to be acceptable to patients and that most patients said they would be willing to pay for it. This service may offer an opportunity to promote inter-professional collaboration between pharmacists and general practitioners.
背景
社区药房服务在控制与药物使用相关的一些因素方面发挥着重要作用,患者可以从这些服务中受益,以提高他们对药物的依从性和知识,同时减少与药物相关的问题。
目的
REVISA 项目旨在对西班牙社区药房实施药物使用审查服务进行初步研究。
地点
西班牙所有地区的 64 家社区药房。
方法
采用便利抽样的方法,对自愿参与的社区药房进行了初步实施、横断面多中心研究。通过结构化访谈,药剂师可以更好地了解患者的药物使用情况。
主要结果测量
药物使用审查相关的时间和成本、满意度和支付意愿。
结果
共纳入 495 名患者。患者的平均年龄为 66.1 岁,其中女性占 56.4%,平均用药 5.7 种。共评估了 2811 种药物,提出了 550 项转诊建议(29.8%至初级保健)。药剂师在药物使用审查服务中花费的平均时间为 52.8 分钟(与药物使用审查相关的费用为 17.27 欧元)。大多数患者对这项服务表示高度满意(98.5%),并表示愿意为此付费(84%)。
结论
西班牙社区药房的药物使用审查服务可以提供,它似乎可以被患者接受,而且大多数患者表示愿意为此付费。这项服务可能为药剂师和全科医生之间的专业合作提供机会。